title: Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1.
authors.affiliation: Institut Gustave-Roussy, Villejuif, France.
authors.forename: A
authors.initials: A
authors.lastname: Ibrahim
authors.forename: J L
authors.initials: JL
authors.lastname: Pico
authors.forename: D
authors.initials: D
authors.lastname: Maraninchi
authors.forename: E
authors.initials: E
authors.lastname: Zambon
authors.forename: M
authors.initials: M
authors.lastname: Attal
authors.forename: P
authors.initials: P
authors.lastname: Brault
authors.forename: H
authors.initials: H
authors.lastname: Tilly
authors.forename: D
authors.initials: D
authors.lastname: Blaise
authors.forename: M
authors.initials: M
authors.lastname: Hayat
mesh_terms: D000293:Adolescent; D000328:Adult; D000527:Alprostadil / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004341:Drug Evaluation; D006504:Hepatic Veno-Occlusive Disease / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008875:Middle Aged; D009369:Neoplasms / Q000601:surgery; D010865:Pilot Projects
chemical_list: D000527:Alprostadil